Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Thomas Capiris is active.

Publication


Featured researches published by Thomas Capiris.


Bioorganic & Medicinal Chemistry Letters | 1998

Pyrazolo[1,5-a]pyrimidine CRF-1 receptor antagonists

David Juergen Wustrow; Thomas Capiris; Ronald Rubin; James A. Knobelsdorf; Hyacinth Akunne; M. Duff Davis; Robert MacKenzie; Thomas A. Pugsley; Kim Zoski; Thomas G. Heffner; Lawrence D. Wise

A series of 3-phenylpyrazolo[1,5-a]pyrimidines was prepared and found to have affinity for the human CRF-1 receptor. The 3-dimensional structure of one of the most potent analogs in this series, 10d, was determined by X-ray crystallography and suggests the spatial requirements for potent CRF-1 receptor binding affinity in this series.


Bioorganic & Medicinal Chemistry Letters | 2009

Oxadiazolone bioisosteres of pregabalin and gabapentin.

David Juergen Wustrow; Thomas Richard Belliotti; Thomas Capiris; Clare Octavia Kneen; Justin Stephen Bryans; Mark J. Field; Dic Williams; Ayman El-Kattan; Lisa Buchholz; Jack J. Kinsora; Susan M. Lotarski; Mark G. Vartanian; Charles P. Taylor; Sean Donevan; Andrew John Thorpe; Jacob Bradley Schwarz

A series of oxadiazolone bioisosteres of pregabalin 1 and gabapentin 2 were prepared, and several were found to exhibit similar potency for the alpha(2)-delta subunit of voltage-gated calcium channels. Oxadiazolone 9 derived from 2 achieved low brain uptake but was nevertheless active in models of osteoarthritis. The high clearance associated with compound 9 was postulated to be a consequence of efflux by OAT and/or OCT, and was attenuated on co-administration with cimetidine or probenecid.


Journal of Medicinal Chemistry | 2005

Structure−Activity Relationships of Pregabalin and Analogues That Target the α2-δ Protein

Thomas Richard Belliotti; Thomas Capiris; I. Victor Ekhato; Jack J. Kinsora; Mark J. Field; Thomas G. Heffner; Leonard T. Meltzer; Jacob Bradley Schwarz; Charles P. Taylor; Andrew John Thorpe; Mark G. Vartanian; Lawrence D. Wise; Ti Zhi-Su; Mark L. Weber; David Juergen Wustrow


Archive | 1998

1-substituted-1-aminomethyl-cycloalkane derivatives (= gabapentin analogues), their preparation and their use in the treatment of neurological disorders

Justin Stephen Bryans; Thomas Capiris; David Christopher Horwell; Clare Octavia Kneen; David Juergen Wustrow


Archive | 1998

Novel amines as pharmaceutical agents

Thomas Richard Belliotti; Justin Stephen Bryans; Thomas Capiris; David Christopher Horwell; Clare Octavia Kneen; David Juergen Wustrow


Journal of Medicinal Chemistry | 1997

Chromeno[3,4-c]pyridin-5-ones: Selective Human Dopamine D4 Receptor Antagonists as Potential Antipsychotic Agents

Paul C. Unangst; Thomas Capiris; David T. Connor; Thomas G. Heffner; Robert G. MacKenzie; Steven Robert Miller; and Thomas A. Pugsley; Lawrence D. Wise


Bioorganic & Medicinal Chemistry Letters | 2006

Carboxylate bioisosteres of gabapentin.

Carmen E. Burgos-Lepley; Lisa R. Thompson; Clare Octavia Kneen; Simon A. Osborne; Justin Stephen Bryans; Thomas Capiris; Nirmala Suman-Chauhan; David J. Dooley; Cindy M. Donovan; Mark J. Field; Mark G. Vartanian; Jack J. Kinsora; Susan M. Lotarski; Ayman El-Kattan; Karen Walters; Madhu Cherukury; Charles P. Taylor; David Juergen Wustrow; Jacob Bradley Schwarz


Archive | 1994

Thiophene-2-carboxamidotetrazoles and pharmaceutical use thereof

Thomas Capiris; David T. Connor


Archive | 1991

3,5-DI-TERTIARY-BUTYL-4-HYDROXYPHENYL THIAZOLYL, OXAZOLYL, AND IMIDAZOLYL METHANONES AND RELATED COMPOUNDS AS ANTIINFLAMMATORY AGENTS

Thomas Capiris; David T. Connor; Jagadish C. Sircar


Archive | 1999

Method of treating psychosis and schizophrenia

Thomas Capiris; David T. Connor; Steven Robert Miller; Paul C. Unangst; Lawrence D. Wise

Researchain Logo
Decentralizing Knowledge